Linked Life Data

6878077

Source:http://linkedlifedata.com/resource/pubmed/id/6878077

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1983-9-23
pubmed:abstractText
Transcutaneous PO2 (tcPO2) has been shown to closely approximate arterial PO2 (PaO2) in infants with normal oxygenation (PaO2 60-100 mm Hg). During hypoxemia (PaO2 less than 60 mm Hg), or administration of vasoactive drugs, such as tolazoline, correlation is frequently so poor that tcPO2 monitoring is of little value. We examined the relationship of tcPO2 to PaO2 among 6 infants with cyanotic congenital heart disease who were receiving prostaglandin E1 (PGE1). Close, linear correlation was found, even during hypoxemia. We conclude that tcPO2 monitoring has potential clinical value in such patients.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0172-0643
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
87-9
pubmed:dateRevised
2008-2-20
pubmed:meshHeading
pubmed:articleTitle
Transcutaneous PO2 monitoring in infants with cyanotic congenital heart disease treated with prostaglandin E1.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.